Delivery Order SPE2DB22D1106-SPE2DB25FDTY8

Award Date 1/11/25
Potential Completion Date 1/13/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,962.11 firm fixed-price delivery order is for the supply of 4,566,995,841 units of NITROFURANTOIN MONO-MCR 100 MG 1000S, a generic pharmaceutical product. The contract has an ultimate completion date of January 22, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,026.77 firm fixed-price delivery order is for the supply of NITROFURANTOIN MCR 50 MG CAP 100S, a pharmaceutical product. The award has an ultimate completion date of November 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $14,671.65, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order awarded under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,960,849 units of the pharmaceutical product Nitrofurantoin Mono-MCR 100 MG. The $1,531.01 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the federal...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $21,630.93 delivery order from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of NITROFURANTOIN MONO-MCR 100 MG 100S, a pharmaceutical product, to support military and government medical programs. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the...
This federal contract award, valued at $1,224.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4566340880 - NITROFURANTOIN 25 MG/5 ML SUSP 230ML, with an ultimate completion date of November 6, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, with an ID of SPE2DB20D3104|SPE2DB24FV4P8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,403.41 firm fixed-price delivery order is for the supply of NITROFURANTOIN MONO-MCR 100 MG 100S, a pharmaceutical product, with a completion date of January 18, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $30,697.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,182,939 units of Nitrofurantoin Mono-MCR 100 mg medication to support federal healthcare programs. The award is a firm-fixed-price delivery order with a completion date of December 28, 2023. This contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,607.92, is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product. The contract has a firm fixed price and has a period of performance through May 14, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $26,116.35 for the supply of 4,562,252 units of NITROFURANTOIN MONO-MCR 100 MG. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 21, 2023. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FDTY8
    Delivery Order

This federal contract award, valued at $2,235.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NITROFURANTOIN MONO-MCR 100 MG 100S, a medical product, with a performance period through January 13, 2025.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The contract award reviewed does not have a set-aside designation, indicating open competition.

Generated 5/21/25, 10:10 AM